This inventor holds 17 USPTO granted patents and 1 EPO patent. Top assignees: Immunex Corporation, American Cyanamid Company, Amgen Inc.. Active years: 1998-2010.
Company Filing History:
15 out of 451 
1 out of 3,580 
1 out of 2,069 
Years Active: 1998-2010
Title: The Innovative Contributions of Dean K Pettit
Introduction
Dean K Pettit is a prominent inventor based in Seattle, WA, known for his significant contributions to the field of biomedical research. With a total of 17 patents to his name, Pettit has made remarkable advancements, particularly in the area of interleukin-15 antagonists. His work has implications for treating various disease states, showcasing his dedication to improving healthcare outcomes.
Latest Patents
Among his latest patents, Pettit has developed antagonists of interleukin-15. These antagonists include muteins of IL-15 and modified IL-15 molecules that bind to the IL-15Rα-subunit without transducing a signal through the β- or γ-subunits of the IL-15 receptor complex. Additionally, he has created monoclonal antibodies against IL-15 that prevent signal transduction through these subunits. His methods of treating conditions such as allograft rejection and graft-versus-host disease highlight the therapeutic potential of his innovations.
Career Highlights
Throughout his career, Pettit has worked with notable companies, including Immunex Corporation and American Cyanamid Company. His experience in these organizations has contributed to his expertise and success as an inventor. His work has not only advanced scientific understanding but has also paved the way for new treatment options in the medical field.
Collaborations
Pettit has collaborated with esteemed colleagues, including Kenneth H Grabstein and Raymond J Paxton. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.
Conclusion
Dean K Pettit’s contributions to the field of biomedical research through his patents and collaborations demonstrate his commitment to advancing medical science. His work continues to have a lasting impact on the treatment of various diseases, showcasing the importance of innovation in healthcare.